Supernus Pharmaceuticals (SUPN) Asset Utilization Ratio (2012 - 2025)

Supernus Pharmaceuticals (SUPN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.5 in Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.5, up 2.52% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.5 (up 2.52% YoY), and the FY2025 annual result was 0.51, up 1.89% from the prior year.
• Asset Utilization Ratio rose to 0.5 in Q4 2025 per SUPN's latest filing, from 0.49 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.5 in Q4 2025 and troughed at 0.36 in Q4 2021.
• A 5-year average of 0.43 and a median of 0.44 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio dropped 2.21% in 2022, then gained 21.75% in 2023.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.36 in 2021, then climbed by 9.95% to 0.39 in 2022, then advanced by 20.64% to 0.47 in 2023, then gained by 2.99% to 0.49 in 2024, then gained by 2.52% to 0.5 in 2025.
• Business Quant data shows SUPN's Asset Utilization Ratio at 0.5 in Q4 2025, 0.49 in Q3 2025, and 0.49 in Q2 2025.